arrow
D

David G. Maloney

Fred Hutchinson Cancer Center
H指数:110
被引数:5.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies

关于未来早期CAR T疗法研究中定义嵌合抗原受体T细胞(CAR T)剂量限制性毒性(DLTs)的建议

2025-11-070
PRE
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials

Gamma-分泌酶抑制剂对BCMA CAR-T疗法后多发性骨髓瘤结局的影响:两项I期试验的比较

2025-09-080
PRE
TNFα Apoptotic Signaling By Antigen-Engaged CAR T-Cells Mediates Clearance of Target Antigen-Negative Acute Myeloid Leukemia

TNFα介导的抗原激活CAR T细胞凋亡信号清除靶抗原阴性的急性髓系白血病

BLOOD
IF23.1
2024-11-050
PRE
PD-L1+ macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy

PD-L1巨噬细胞和肿瘤细胞的丰度以及与T细胞的邻近性在预处理大b细胞淋巴瘤微环境中影响CD19 car-t细胞免疫治疗的疗效

2024-08-071
OAAI
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

anti-PD-L1抗体起始时间影响CD19 car-t细胞治疗大b细胞淋巴瘤的疗效/毒性

2024-01-2311
OAAI
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

与CD19 CAR T细胞治疗复发/难治性CLL的长期结果相关的因素

2023-11-177
OAAI
Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy

嵌合抗原受体T细胞治疗后巨细胞病毒 (CMV) 再激活和CMV特异性细胞介导的免疫

2023-11-1718
OAAI
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004) a multicentre, open-label, single-arm, phase 1-2 study
LANCET
IF88.5
2023-08-0149
PRE
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Anakinra治疗嵌合抗原受体T细胞治疗后难治性细胞因子释放综合征或免疫效应细胞相关神经毒性综合征

2023-07-0160
OAAI
A2B530, AN AUTOLOGOUS CEA-DIRECTED TMOD TCELL THERAPY WITH AN INHIBITORY RECEPTOR GATED BY HLA-A*02 TO TARGET COLORECTAL, PANCREATIC, AND LUNG CANCER
2022-11-071
OA
Use of Magnetic Resonance Imaging in Neuroprognostication After Pediatric Cardiac Arrest: Survey of Current Practices

磁共振成像在小儿心脏骤停后神经预后中的应用: 当前实践调查

2022-09-015
OAAI
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
LANCET
IF88.5
2022-06-01396
PRE